Updated:
Spex Capital
Spex Capital is a UK-based early-stage venture and growth equity firm deploying across seed, start-up, and growth rounds from Esher.
Spex Capital
Spex Capital is a venture capital firm focused on the healthcare sector. It invests in early-stage digital healthcare and med-tech startups, primarily in the UK. Founded in 2021, Spex Capital is based in London, England.
General information
Firm type
Private Equity
Year founded
—
AUM
Undisclosed
Location
Region
Europe
Country
United Kingdom
City
Esher
Corporate office
Esher, United Kingdom
Frequently asked questions
What investment stages does Spex Capital target?
Spex Capital targets early-stage opportunities including seed and start-up rounds, alongside growth-stage investments. The firm's mandate spans venture capital and growth equity, allowing it to participate in a company's funding lifecycle from inception through later rounds.
Does Spex Capital focus on specific sectors?
Based on available public record, Spex Capital maintains a generalist investment mandate without a publicly stated sector specialization. The firm evaluates opportunities across industries rather than limiting its focus to specific verticals.
Who leads investment decisions at Spex Capital?
Spex Capital has not publicly disclosed its investment committee structure or the names of principals leading its investment decisions. The firm's leadership and decision-making architecture remain opaque in the public record.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: